TEHRAN, Young Journalists Club (YJC) -The team recently presented details from a small test that suggested injecting people suffering from the brain disorder with blood plasma is safe, tolerable and provides some respite, at the 10th Clinical Trials on Alzheimer’s Disease in Boston.
The Alzheimer’s Association estimates that around 5 million Americans are living with the form of dementia. By 2050 the health organization estimates that number could rise to a whopping 16 million.
Searching for a cure to the degenerative disease, Stanford University School of Medicine made progress in administering blood plasma infusions to patients suffering from mild to moderate Alzheimer’s disease.
Consisting of 18 patients, the study was geared towards determining if human plasma – which contains enzymes, antibodies and proteins – had any ill-effects on patients.
The trial’s lead investigator, Sharon Sha said not only was the procedure found to have few side effects – itching was observed in the experiment – improvement to functions such as remembering medication was achieved in some instances.